Governance warning as Asian markets boom
Asia’s financial market is tipped to usurp both the US and Europe in the next 15 years to become the prime global powerhouse, an ANZ report suggests.
The landmark study of financial systems, prepared by ANZ’s chief economist Warren Hogan, found Asia, which currently occupies around 22 per cent of the global system, could account for half by 2030.
Asian bond markets are forecast to grow to six times their current size over the period, while equity market capitalisation is tipped to “explode” to US$55 trillion, from its current US$9 trillion.
The “techtonic shift” will more broadly benefit global markets, with a wider spread of financial flows.
“Instead of the benign flow of official capital into deep, liquid government bond markets, particularly US
treasury bonds, Asia’s private sector will have a much bigger role in allocating Asian savings around the world,” Hogan said.
However, the transformation will be dependent upon the reform and deregulation of many Asian nations, according to the report.
“Government policy will be crucial in mitigating any problems as Asia develops a large, open and sophisticated financial system,” Hogan said.
“The decisions Chinese policymakers make in coming years will be of great importance to the global financial system.”
Improved access to capital, as well as refined legal structures, will also be key, Hogan said.
Recommended for you
The increased bids for Insignia from Bain and CC Capital value the company at $3.3 billion, while there is still a possibility for competing bids from rival players such as Brookfield.
AMP and Clime Investment Management have shared how they are harnessing the power of social media to help the firms reach a younger demographic and increase brand awareness.
The number of Australian individuals with more than US$10 million in assets has passed 42,000, rising by 3.9 per cent over the past year.
A former Northern Territory financial adviser has received a seven-year ban from ASIC, having been convicted of supplying dangerous drugs and receiving or possessing the proceeds of their sale.
